Blue Moonshine

Alaska, developed by Tikun Olam, is an Israeli strain comprised of 70% sativa genetics. With uplifting effects intended for daytime consumption, Alaska has been found to successfully treat an array of medical symptoms including inflammation, pain, nausea, insomnia, and gastrointestinal disorders.

From Barney’s Farm comes CBD Critical Cure (or simply “Critical Cure”), an indica-dominant strain that’s said to combine Critical Kush with a ruderalis variety. Because this strain typically contains about 8 percent CBD and 5 percent THC, Critical Cure can annihilate pain, stress, and inflammation with little psychoactive interference. The indica influence in CBD Critical Cure gives rise to deeply relaxing effects delivered alongside a sweet, earthy flavor.

This lesser-known strain is a classic indica that provides patients with reliable and lengthy pain and stress relief. The effects transition from light and floaty to the heavy sedation typical of indica plants. Black Label Kush has a strong pungence bordering on the harsh side, but provides a rich medicating experience.

Beast Mode 2.0, also known as BlueFire OG, is an indica-dominant hybrid of Master Kush and White Fire OG. It is a proprietary strain distributed by Green Umbrella in Seattle, and bred by Grass Roots Pharm. The strain was developed on the heels of Green Umbrella's other successful proprietary strain, Beast Mode OG. After another successful season for both Beast Mode OG and Seattle’s infamous running back, Grass Roots Pharm and Green Umbrella collaborated to bring Beast Mode 2.0 to the medical market, with plans to make it available for recreational consumption later this summer. Beast Mode 2.0 has a sweet mix of earthy berry and piney Kush flavors and has tested as high as 23% total cannabinoids by Steep Hill Lab. The effects of this hybrid are steered by the heavy indica properties that medical patients seek when fighting chronic pain, sleeplessness, or a lack of appetite.